Patent details

EP2900277 Title: DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

Basic Information

Publication number:
EP2900277
PCT Application Number:
US2013051667
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138616586
PCT Publication Number:
WO2014092804
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY
French Title of Invention:
DOSAGES D'IMMUNO-CONJUGUÉS D'ANTICORPS ET DE SN-38 POUR AMÉLIORER L'EFFICACITÉ ET RÉDUIRE LA TOXICITÉ
German Title of Invention:
DOSIERUNGEN VON IMMUNKONJUGATEN VON ANTIKÖRPERN UND SN-38 FÜR VERBESSERTE WIRKSAMKEIT UND REDUZIERTE TOXIZITÄT
SPC Number:

Dates

Filing date:
23/07/2013
Grant date:
16/02/2022
EP Publication Date:
05/08/2015
PCT Publication Date:
19/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/02/2022
EP B1 Publication Date:
16/02/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/02/2022
 
 

Name:
Immunomedics, Inc.
Address:
300 American Road, Morris Plains, NJ 07950, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/02/2022
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GOLDENBERG, David, M.
Address:
United States (US)

2

Name:
GOVINDAN, Serengulam, V.
Address:
United States (US)

Priority

1

Priority Number:
201261736684 P
Priority Date:
13/12/2012
Priority Country:
United States (US)

2

Priority Number:
201361749548 P
Priority Date:
07/01/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 47/68; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202207
Publication date:
16/02/2022
Description:
Grant (B1)

2

Issue number:
202212
Publication date:
23/03/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
14/07/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/02/2022 Power Of Attorney 1
18/02/2022 Outgoing Correspondence 1